{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tb-500-corticosteroids","title":"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence","body":"## What's breaking down\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why Corticosteroid injections matters for you\n1. **Drug:** Corticosteroid injections\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\n\n## How these fit together\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\n\n## What the evidence actually shows\nA 2026 scoping review of 80 studies on thymosin beta-4 and TB-500 found the evidence base weighted toward in vitro and mixed designs. Musculoskeletal categories (tendon, ligament, muscle, cartilage, spine) were sparse. No human interventional studies of administered TB-500 or TB4 were identified for tendon, ligament, muscle, bone, cartilage or spine applications (preclinical tier, source_ids s21). Human data for TB4 concentrates in ocular/cornea and wound/skin/soft tissue settings.\n\nAnimal and in vitro work shows Tβ4 promotes cell migration, angiogenesis, and reduced scar tissue in muscle, tendon, and ligament models (preclinical tier). Corticosteroid studies document tendon weakening and rupture risk, cartilage thinning, and collagen synthesis suppression in human clinical observations and histology (human tier).\n\n## What scientists say\nResearchers note Tβ4 accelerates healing processes in animal tendon and ligament models via actin sequestration and cell migration. Reviews highlight the gap in direct human musculoskeletal interventional trials for administered TB-500. Corticosteroid literature consistently flags local tissue catabolic effects as a known limitation of repeated use.\n\n## What people say on Reddit\nUsers on r/steroids and r/PlantarFasciitis report stacking TB-500 with BPC-157 for soft-tissue recovery, often after or alongside cortisone shots. Anecdotes describe faster perceived healing timelines but note expense and variable sourcing. Several threads highlight cortisone's tendon-weakening reputation as motivation for trying peptides (anecdotal tier).\n\n## What people say on X\nPosts discuss TB-500 for immune cell migration to injury sites and pairing with other peptides for recovery, sometimes in context of steroid cycles. Mentions emphasize animal data strength versus limited human trials and regulatory status (anecdotal tier).\n\n## What we do not know\nNo large randomized human trials exist for TB-500 specifically with corticosteroid exposure or for common musculoskeletal conditions. Long-term safety data in humans for repeated TB-500 use remains absent. Interaction mechanisms between exogenous TB-500 fragments and corticosteroid-induced collagen changes are not mapped in clinical settings.\n\n## Safety and limits\nCorticosteroid injections carry documented local risks including tendon rupture, atrophy, and hypopigmentation. TB-500 evidence is predominantly preclinical with minimal direct human musculoskeletal data. Both approaches require individualized medical evaluation; neither is positioned as a cure or replacement for standard care.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-corticosteroids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2026 scoping review of 80 studies found no human interventional trials of administered TB4 or TB-500 for tendon, ligament, muscle, bone, cartilage or spine applications.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s21"],"source_status":"sourced","why_material":"Establishes the human evidence gap for MSK use of TB-500.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Repeated corticosteroid injections are linked to tendon weakening, collagen suppression, and increased rupture risk in human clinical observations.","section":"Why Corticosteroid injections matters for you","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Highlights the suppression vs repair trade-off central to the article.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 pathways that promote cell migration and actin organization in tissue repair models.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s22"],"source_status":"sourced","why_material":"Directly supports the if-then logic for the peptide section.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s21","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review","quote":"No human interventional studies of administered TB4 or TB-500 were identified in tendon, ligament, muscle, bone, cartilage, adipose/fat graft, or spine/intervertebral disc categories","summary":"2026 scoping review mapping 80 studies; MSK human interventional data absent.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"384e11d5523ce2166af7348eafc7815081ce03945a17f4019a5cb11ebcc4674a"},{"id":"s0","type":"medical","url":"https://rosm.org/dangers-of-cortisone-injections/","title":"The Hidden Dangers of Cortisone Injections for Tendons and Joints","quote":"Repeated cortisone injections can weaken tendons, making them prone to full-thickness tears.","summary":"Clinical review of corticosteroid risks including tendon and cartilage damage.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"ok","quote_status":"verified","prev":"384e11d5523ce2166af7348eafc7815081ce03945a17f4019a5cb11ebcc4674a","hash":"760198777cb5d33cccf82edeea240867fd46ca9efc175af85765a61bb29f4792"},{"id":"s22","type":"medical","url":"https://www.jeffreypengmd.com/post/tb-500-for-injury-recovery-what-the-research-actually-shows","title":"TB-500 for Injury Recovery | What the Research Actually Shows","quote":"A comprehensive review in Frontiers in Endocrinology details how Tβ4 accelerates healing in muscle, tendon, and ligament injuries by stimulating cell migration","summary":"Summarizes Tβ4 mechanisms from animal and review literature.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"ok","quote_status":"unverified","prev":"760198777cb5d33cccf82edeea240867fd46ca9efc175af85765a61bb29f4792","hash":"4cba8f3788709d961626a3fcb9d17666a666d38056f5d329722fb46f1be8a91f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:40:01.096Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence","register":"source_ledger","body":"## What's breaking down\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why Corticosteroid injections matters for you\n1. **Drug:** Corticosteroid injections\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\n\n## How these fit together\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\n\n## What the evidence actually shows\nA 2026 scoping review of 80 studies on thymosin beta-4 and TB-500 found the evidence base weighted toward in vitro and mixed designs. Musculoskeletal categories (tendon, ligament, muscle, cartilage, spine) were sparse. No human interventional studies of administered TB-500 or TB4 were identified for tendon, ligament, muscle, bone, cartilage or spine applications (preclinical tier, source_ids s21). Human data for TB4 concentrates in ocular/cornea and wound/skin/soft tissue settings.\n\nAnimal and in vitro work shows Tβ4 promotes cell migration, angiogenesis, and reduced scar tissue in muscle, tendon, and ligament models (preclinical tier). Corticosteroid studies document tendon weakening and rupture risk, cartilage thinning, and collagen synthesis suppression in human clinical observations and histology (human tier).\n\n## What scientists say\nResearchers note Tβ4 accelerates healing processes in animal tendon and ligament models via actin sequestration and cell migration. Reviews highlight the gap in direct human musculoskeletal interventional trials for administered TB-500. Corticosteroid literature consistently flags local tissue catabolic effects as a known limitation of repeated use.\n\n## What people say on Reddit\nUsers on r/steroids and r/PlantarFasciitis report stacking TB-500 with BPC-157 for soft-tissue recovery, often after or alongside cortisone shots. Anecdotes describe faster perceived healing timelines but note expense and variable sourcing. Several threads highlight cortisone's tendon-weakening reputation as motivation for trying peptides (anecdotal tier).\n\n## What people say on X\nPosts discuss TB-500 for immune cell migration to injury sites and pairing with other peptides for recovery, sometimes in context of steroid cycles. Mentions emphasize animal data strength versus limited human trials and regulatory status (anecdotal tier).\n\n## What we do not know\nNo large randomized human trials exist for TB-500 specifically with corticosteroid exposure or for common musculoskeletal conditions. Long-term safety data in humans for repeated TB-500 use remains absent. Interaction mechanisms between exogenous TB-500 fragments and corticosteroid-induced collagen changes are not mapped in clinical settings.\n\n## Safety and limits\nCorticosteroid injections carry documented local risks including tendon rupture, atrophy, and hypopigmentation. TB-500 evidence is predominantly preclinical with minimal direct human musculoskeletal data. Both approaches require individualized medical evaluation; neither is positioned as a cure or replacement for standard care.","claims":[{"id":"c1","text":"A 2026 scoping review of 80 studies found no human interventional trials of administered TB4 or TB-500 for tendon, ligament, muscle, bone, cartilage or spine applications.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s21"],"source_status":"sourced","why_material":"Establishes the human evidence gap for MSK use of TB-500.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Repeated corticosteroid injections are linked to tendon weakening, collagen suppression, and increased rupture risk in human clinical observations.","section":"Why Corticosteroid injections matters for you","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Highlights the suppression vs repair trade-off central to the article.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 pathways that promote cell migration and actin organization in tissue repair models.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s22"],"source_status":"sourced","why_material":"Directly supports the if-then logic for the peptide section.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s21","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review","quote":"No human interventional studies of administered TB4 or TB-500 were identified in tendon, ligament, muscle, bone, cartilage, adipose/fat graft, or spine/intervertebral disc categories","link_status":"http_403","quote_status":"unverified"},{"id":"s0","type":"medical","url":"https://rosm.org/dangers-of-cortisone-injections/","title":"The Hidden Dangers of Cortisone Injections for Tendons and Joints","quote":"Repeated cortisone injections can weaken tendons, making them prone to full-thickness tears.","link_status":"ok","quote_status":"verified"},{"id":"s22","type":"medical","url":"https://www.jeffreypengmd.com/post/tb-500-for-injury-recovery-what-the-research-actually-shows","title":"TB-500 for Injury Recovery | What the Research Actually Shows","quote":"A comprehensive review in Frontiers in Endocrinology details how Tβ4 accelerates healing in muscle, tendon, and ligament injuries by stimulating cell migration","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":36305,"tokens_out":2659,"cost":0.05202875,"prev_hash":"genesis","hash":"27cb6e605e30b6ae1298c63f731a338768fa55fe510aadb0257708008267e7d2"}],"provenance":[{"ts":"2026-06-29T23:40:01.096Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Corticosteroids\nSlug: tb-500-corticosteroids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[\"corticosteroid-injection\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains","response":"{\n  \"slug\": \"tb-500-corticosteroids\",\n  \"title\": \"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence\",\n  \"body\": \"## What's breaking down\\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\\n\\n## Why TB-500 might help you\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\n## Why Corticosteroid injections matters for you\\n1. **Drug:** Corticosteroid injections\\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\\n\\n## How these fit together\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **TB-500** → inflammation clearance / repair-cell migration\\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\\n\\n## What the evidence actually shows\\nA 2026 scoping review","tokens_in":36305,"tokens_out":2659,"cost":0,"prev":"genesis","hash":"4902641e97786eb51123ce24ef8fe7c4da4746b51fa291ec2fece2614c93a508"},{"ts":"2026-07-17T02:42:13.787Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-corticosteroids","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4902641e97786eb51123ce24ef8fe7c4da4746b51fa291ec2fece2614c93a508","hash":"9075ebcfda4acb104948e15366c3ef40b6d645c51914e5d7e713d45afe4b20cb"}],"energy":{"passes":2,"tokens_in":36305,"tokens_out":2659,"tokens_total":38964,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"9075ebcfda4acb104948e15366c3ef40b6d645c51914e5d7e713d45afe4b20cb"},"posted_at":"2026-06-29T21:33:27.029Z","created_at":"2026-06-29T21:33:27.029Z","updated_at":"2026-07-17T02:42:13.787Z","machine":{"shape":"article.machine/v1","slug":"tb-500-corticosteroids","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-corticosteroids","json":"https://miscsubjects.com/api/articles/tb-500-corticosteroids","bundle":"https://miscsubjects.com/api/articles/tb-500-corticosteroids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-corticosteroids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-corticosteroids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-corticosteroids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-corticosteroids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-corticosteroids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-corticosteroids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-corticosteroids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-corticosteroids","json":"/api/articles/tb-500-corticosteroids","markdown":"/api/articles/tb-500-corticosteroids/bundle?format=markdown","skill":"/api/articles/tb-500-corticosteroids/skill","topology":"/api/articles/tb-500-corticosteroids/topology","versions":"/api/articles/tb-500-corticosteroids/revisions","invocations":"/api/articles/tb-500-corticosteroids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-corticosteroids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"78dddd72c54292d4f7ec25498f67ed0cc78aa6759a902f308cfd5f6e80126bd5","object":{"object_type":"article-object","identity":{"id":"article:tb-500-corticosteroids","slug":"tb-500-corticosteroids","title":"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tb-500-corticosteroids","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tb-500-corticosteroids/skill","role":"direct behavior","audience":"model","content":"---\nname: tb-500-corticosteroids\ndescription: Apply the TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence\n\nThis Skill is the behavioral expression of [the canonical article](/a/tb-500-corticosteroids). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tb-500-corticosteroids.\n- Read claims and relationships at /api/articles/tb-500-corticosteroids/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Corticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collage\n\n## Representations\n\n- Human: /a/tb-500-corticosteroids\n- JSON: /api/articles/tb-500-corticosteroids\n- Relationships: /api/articles/tb-500-corticosteroids/topology\n- History: /api/articles/tb-500-corticosteroids/revisions\n"},"json":{"route":"/api/articles/tb-500-corticosteroids","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tb-500-corticosteroids/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tb","500","corticosteroids"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tb-500-corticosteroids/invocations?status=success","failure_events":"/api/articles/tb-500-corticosteroids/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tb-500-corticosteroids","title":"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence","body":"## What's breaking down\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why Corticosteroid injections matters for you\n1. **Drug:** Corticosteroid injections\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\n\n## How these fit together\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\n\n## What the evidence actually shows\nA 2026 scoping review of 80 studies on thymosin beta-4 and TB-500 found the evidence base weighted toward in vitro and mixed designs. Musculoskeletal categories (tendon, ligament, muscle, cartilage, spine) were sparse. No human interventional studies of administered TB-500 or TB4 were identified for tendon, ligament, muscle, bone, cartilage or spine applications (preclinical tier, source_ids s21). Human data for TB4 concentrates in ocular/cornea and wound/skin/soft tissue settings.\n\nAnimal and in vitro work shows Tβ4 promotes cell migration, angiogenesis, and reduced scar tissue in muscle, tendon, and ligament models (preclinical tier). Corticosteroid studies document tendon weakening and rupture risk, cartilage thinning, and collagen synthesis suppression in human clinical observations and histology (human tier).\n\n## What scientists say\nResearchers note Tβ4 accelerates healing processes in animal tendon and ligament models via actin sequestration and cell migration. Reviews highlight the gap in direct human musculoskeletal interventional trials for administered TB-500. Corticosteroid literature consistently flags local tissue catabolic effects as a known limitation of repeated use.\n\n## What people say on Reddit\nUsers on r/steroids and r/PlantarFasciitis report stacking TB-500 with BPC-157 for soft-tissue recovery, often after or alongside cortisone shots. Anecdotes describe faster perceived healing timelines but note expense and variable sourcing. Several threads highlight cortisone's tendon-weakening reputation as motivation for trying peptides (anecdotal tier).\n\n## What people say on X\nPosts discuss TB-500 for immune cell migration to injury sites and pairing with other peptides for recovery, sometimes in context of steroid cycles. Mentions emphasize animal data strength versus limited human trials and regulatory status (anecdotal tier).\n\n## What we do not know\nNo large randomized human trials exist for TB-500 specifically with corticosteroid exposure or for common musculoskeletal conditions. Long-term safety data in humans for repeated TB-500 use remains absent. Interaction mechanisms between exogenous TB-500 fragments and corticosteroid-induced collagen changes are not mapped in clinical settings.\n\n## Safety and limits\nCorticosteroid injections carry documented local risks including tendon rupture, atrophy, and hypopigmentation. TB-500 evidence is predominantly preclinical with minimal direct human musculoskeletal data. Both approaches require individualized medical evaluation; neither is positioned as a cure or replacement for standard care.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-corticosteroids/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"A 2026 scoping review of 80 studies found no human interventional trials of administered TB4 or TB-500 for tendon, ligament, muscle, bone, cartilage or spine applications.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s21"],"source_status":"sourced","why_material":"Establishes the human evidence gap for MSK use of TB-500.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Repeated corticosteroid injections are linked to tendon weakening, collagen suppression, and increased rupture risk in human clinical observations.","section":"Why Corticosteroid injections matters for you","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Highlights the suppression vs repair trade-off central to the article.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 pathways that promote cell migration and actin organization in tissue repair models.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s22"],"source_status":"sourced","why_material":"Directly supports the if-then logic for the peptide section.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s21","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review","quote":"No human interventional studies of administered TB4 or TB-500 were identified in tendon, ligament, muscle, bone, cartilage, adipose/fat graft, or spine/intervertebral disc categories","summary":"2026 scoping review mapping 80 studies; MSK human interventional data absent.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"http_403","quote_status":"unverified","prev":"genesis","hash":"384e11d5523ce2166af7348eafc7815081ce03945a17f4019a5cb11ebcc4674a"},{"id":"s0","type":"medical","url":"https://rosm.org/dangers-of-cortisone-injections/","title":"The Hidden Dangers of Cortisone Injections for Tendons and Joints","quote":"Repeated cortisone injections can weaken tendons, making them prone to full-thickness tears.","summary":"Clinical review of corticosteroid risks including tendon and cartilage damage.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"ok","quote_status":"verified","prev":"384e11d5523ce2166af7348eafc7815081ce03945a17f4019a5cb11ebcc4674a","hash":"760198777cb5d33cccf82edeea240867fd46ca9efc175af85765a61bb29f4792"},{"id":"s22","type":"medical","url":"https://www.jeffreypengmd.com/post/tb-500-for-injury-recovery-what-the-research-actually-shows","title":"TB-500 for Injury Recovery | What the Research Actually Shows","quote":"A comprehensive review in Frontiers in Endocrinology details how Tβ4 accelerates healing in muscle, tendon, and ligament injuries by stimulating cell migration","summary":"Summarizes Tβ4 mechanisms from animal and review literature.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:40:00.325Z","link_status":"ok","quote_status":"unverified","prev":"760198777cb5d33cccf82edeea240867fd46ca9efc175af85765a61bb29f4792","hash":"4cba8f3788709d961626a3fcb9d17666a666d38056f5d329722fb46f1be8a91f"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:40:01.096Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence","register":"source_ledger","body":"## What's breaking down\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\n\n## Why TB-500 might help you\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why Corticosteroid injections matters for you\n1. **Drug:** Corticosteroid injections\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\n\n## How these fit together\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **TB-500** → inflammation clearance / repair-cell migration\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\n\n## What the evidence actually shows\nA 2026 scoping review of 80 studies on thymosin beta-4 and TB-500 found the evidence base weighted toward in vitro and mixed designs. Musculoskeletal categories (tendon, ligament, muscle, cartilage, spine) were sparse. No human interventional studies of administered TB-500 or TB4 were identified for tendon, ligament, muscle, bone, cartilage or spine applications (preclinical tier, source_ids s21). Human data for TB4 concentrates in ocular/cornea and wound/skin/soft tissue settings.\n\nAnimal and in vitro work shows Tβ4 promotes cell migration, angiogenesis, and reduced scar tissue in muscle, tendon, and ligament models (preclinical tier). Corticosteroid studies document tendon weakening and rupture risk, cartilage thinning, and collagen synthesis suppression in human clinical observations and histology (human tier).\n\n## What scientists say\nResearchers note Tβ4 accelerates healing processes in animal tendon and ligament models via actin sequestration and cell migration. Reviews highlight the gap in direct human musculoskeletal interventional trials for administered TB-500. Corticosteroid literature consistently flags local tissue catabolic effects as a known limitation of repeated use.\n\n## What people say on Reddit\nUsers on r/steroids and r/PlantarFasciitis report stacking TB-500 with BPC-157 for soft-tissue recovery, often after or alongside cortisone shots. Anecdotes describe faster perceived healing timelines but note expense and variable sourcing. Several threads highlight cortisone's tendon-weakening reputation as motivation for trying peptides (anecdotal tier).\n\n## What people say on X\nPosts discuss TB-500 for immune cell migration to injury sites and pairing with other peptides for recovery, sometimes in context of steroid cycles. Mentions emphasize animal data strength versus limited human trials and regulatory status (anecdotal tier).\n\n## What we do not know\nNo large randomized human trials exist for TB-500 specifically with corticosteroid exposure or for common musculoskeletal conditions. Long-term safety data in humans for repeated TB-500 use remains absent. Interaction mechanisms between exogenous TB-500 fragments and corticosteroid-induced collagen changes are not mapped in clinical settings.\n\n## Safety and limits\nCorticosteroid injections carry documented local risks including tendon rupture, atrophy, and hypopigmentation. TB-500 evidence is predominantly preclinical with minimal direct human musculoskeletal data. Both approaches require individualized medical evaluation; neither is positioned as a cure or replacement for standard care.","claims":[{"id":"c1","text":"A 2026 scoping review of 80 studies found no human interventional trials of administered TB4 or TB-500 for tendon, ligament, muscle, bone, cartilage or spine applications.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s21"],"source_status":"sourced","why_material":"Establishes the human evidence gap for MSK use of TB-500.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Repeated corticosteroid injections are linked to tendon weakening, collagen suppression, and increased rupture risk in human clinical observations.","section":"Why Corticosteroid injections matters for you","tier":"human","source_ids":["s0"],"source_status":"sourced","why_material":"Highlights the suppression vs repair trade-off central to the article.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"TB-500 is studied for thymosin beta-4 pathways that promote cell migration and actin organization in tissue repair models.","section":"Why TB-500 might help you","tier":"mechanistic","source_ids":["s22"],"source_status":"sourced","why_material":"Directly supports the if-then logic for the peptide section.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:40:00.532Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s21","type":"review","url":"https://www.mdpi.com/2076-3417/16/12/6202","title":"Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review","quote":"No human interventional studies of administered TB4 or TB-500 were identified in tendon, ligament, muscle, bone, cartilage, adipose/fat graft, or spine/intervertebral disc categories","link_status":"http_403","quote_status":"unverified"},{"id":"s0","type":"medical","url":"https://rosm.org/dangers-of-cortisone-injections/","title":"The Hidden Dangers of Cortisone Injections for Tendons and Joints","quote":"Repeated cortisone injections can weaken tendons, making them prone to full-thickness tears.","link_status":"ok","quote_status":"verified"},{"id":"s22","type":"medical","url":"https://www.jeffreypengmd.com/post/tb-500-for-injury-recovery-what-the-research-actually-shows","title":"TB-500 for Injury Recovery | What the Research Actually Shows","quote":"A comprehensive review in Frontiers in Endocrinology details how Tβ4 accelerates healing in muscle, tendon, and ligament injuries by stimulating cell migration","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":36305,"tokens_out":2659,"cost":0.05202875,"prev_hash":"genesis","hash":"27cb6e605e30b6ae1298c63f731a338768fa55fe510aadb0257708008267e7d2"}],"provenance":[{"ts":"2026-06-29T23:40:01.096Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Corticosteroids\nSlug: tb-500-corticosteroids\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[\"corticosteroid-injection\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains","response":"{\n  \"slug\": \"tb-500-corticosteroids\",\n  \"title\": \"TB-500 and Corticosteroid Injections: Repair Pathways vs Suppression Evidence\",\n  \"body\": \"## What's breaking down\\nCorticosteroid injections deliver potent anti-inflammatory effects that suppress signals at the injury site. This can reduce short-term pain and swelling. However, repeated use links to tissue weakening, reduced collagen production, and slower structural repair in tendons, ligaments, and cartilage. The result is a trade-off: symptoms ease while the underlying degeneration layer may persist or worsen because repair pathways stay suppressed.\\n\\n## Why TB-500 might help you\\n1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\\n\\n## Why Corticosteroid injections matters for you\\n1. **Drug:** Corticosteroid injections\\n2. **What it does:** Powerful anti-inflammatory; repeated use linked to tissue weakening.\\n3. **Therefore for you:** This drug suppresses a signal (inflammation) and does not reduce mechanical load or support metabolism. It trades off repair by weakening collagen structures, which can prolong the degeneration cycle even as pain decreases.\\n\\n## How these fit together\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **TB-500** → inflammation clearance / repair-cell migration\\nCorticosteroids handle acute suppression while TB-500 pathways address migration and actin organization. The combination is discussed for cases where suppression alone leaves repair stalled.\\n\\n## What the evidence actually shows\\nA 2026 scoping review","tokens_in":36305,"tokens_out":2659,"cost":0,"prev":"genesis","hash":"4902641e97786eb51123ce24ef8fe7c4da4746b51fa291ec2fece2614c93a508"},{"ts":"2026-07-17T02:42:13.787Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-corticosteroids","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"4902641e97786eb51123ce24ef8fe7c4da4746b51fa291ec2fece2614c93a508","hash":"9075ebcfda4acb104948e15366c3ef40b6d645c51914e5d7e713d45afe4b20cb"}],"energy":{"passes":2,"tokens_in":36305,"tokens_out":2659,"tokens_total":38964,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"9075ebcfda4acb104948e15366c3ef40b6d645c51914e5d7e713d45afe4b20cb"},"posted_at":"2026-06-29T21:33:27.029Z","created_at":"2026-06-29T21:33:27.029Z","updated_at":"2026-07-17T02:42:13.787Z","machine":{"shape":"article.machine/v1","slug":"tb-500-corticosteroids","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-corticosteroids","json":"https://miscsubjects.com/api/articles/tb-500-corticosteroids","bundle":"https://miscsubjects.com/api/articles/tb-500-corticosteroids/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":3,"sources":3,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-corticosteroids/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-corticosteroids","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-corticosteroids\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-corticosteroids\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-corticosteroids/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-corticosteroids\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-corticosteroids | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-corticosteroids","json":"/api/articles/tb-500-corticosteroids","markdown":"/api/articles/tb-500-corticosteroids/bundle?format=markdown","skill":"/api/articles/tb-500-corticosteroids/skill","topology":"/api/articles/tb-500-corticosteroids/topology","versions":"/api/articles/tb-500-corticosteroids/revisions","invocations":"/api/articles/tb-500-corticosteroids/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-corticosteroids","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"78dddd72c54292d4f7ec25498f67ed0cc78aa6759a902f308cfd5f6e80126bd5"}}}